Atlas Trials

Pharmacogenomic Study on PKD/PKC of Dabigatran Etexilate and Rivaroxaban

Clinical trial NCT01627665 · COMPLETED

Trial details

NCT number
NCT01627665
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2011-10-01
Primary completion
2014-06-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.